Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis.

Overbeek, Jetty A; Bakker, Marina; van der Heijden, Amber A W A; van Herk-Sukel, Myrthe P P; Herings, Ron M C; Nijpels, Giel

Overbeek, Jetty A; Bakker, Marina; van der Heijden, Amber A W A; van Herk-Sukel, Myrthe P P; Herings, Ron M C; Nijpels, Giel.

Affiliation

Overbeek JA; Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, Netherlands.
Bakker M; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
van der Heijden AAWA; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
van Herk-Sukel MPP; Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, Netherlands.
Herings RMC; Department of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands.
Nijpels G; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.

Diabetes Metab Res Rev ; 34(5): e3004, 2018 07.

Article in En | MEDLINE | ID: mdl-29573125

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Neoplasms/chemically induced; Clinical Trials as Topic; Humans

Key words

DPP-4 inhibitors; meta-analysis; site-specific cancer; systematic literature review

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Neoplasms Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Diabetes Metab Res Rev Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2018 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google